Tom O’Brien

Lender White Oak has argued it can shield an email that repeats legal advice from Ashurst that was accidentally disclosed to insurers Bond & Credit Company and Tokio Marine, which it has sued over the collapse of supply chain finance company Greensill. 

Engineering firm Clough Projects Australia is challenging a judge's order staying its $54 million cross-claim against former Energy Connection joint venture partner Elecnor.

Real estate asset manager Dexus wants information that the Asia Pacific Airport Corporation gave to several consultants in a court battle over allegations it breached a shareholder deed in selling a stake in the airport operator. 

Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.

Mayne Pharma has denied US drug maker Cosette's claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.

A court has heard US drug maker Cosette may amend its case to accuse Adelaide's Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.

Mayne Pharma has said it may seek to shut out US drug maker Cosette's expert evidence in proceedings over the purported termination of their $672 million merger.

A judge has stayed engineering firm Clough’s $54 million cross-claim against its former joint venture partner on the EnergyConnect transmission project, Elecnor, saying the claim must be sent to arbitration.

Insurer Marsh has fired off a cross-claim against Swiss bank UBS in several cases brought over Greensill’s $1.7 billion collapse. 

Australia’s largest brick manufacturer Brickworks has settled a competition case brought against rival BGC, a company founded by billionaire Len Buckeridge.